Lindsey Rolfe
CIK 1650504 · See Remarks · last filed 2026-01-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
64
Lifetime Open-Market Net
-$1.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Director | — | $0.05 | — | $0 | 6 | 2026-01-09 |
| Atreca, Inc. (BCEL) Delisted | Director | — | $0.15 | — | $0 | 5 | 2023-06-15 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 113,327 | $0.08 | $9.2K | -$1.35M | 53 | 2022-11-03 |
Recent Filings · Page 2 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +2,412 | -$1.7K | EDGAR |
| 2022-05-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +4,122 | -$8.4K | EDGAR |
| 2022-03-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +9,993 | -$20.4K | EDGAR |
| 2022-02-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +3,861 | -$8.8K | EDGAR |
| 2021-12-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +341 | -$1.0K | EDGAR |
| 2021-11-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +4,165 | -$19.2K | EDGAR |
| 2021-09-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +341 | -$1.7K | EDGAR |
| 2021-08-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +4,179 | -$20.2K | EDGAR |
| 2021-06-11 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.